Clinical Research Directory
Browse clinical research sites, groups, and studies.
Pharmacist-led Intervention for Injectable HIV Treatment for Women With Health-related Social Needs
Sponsor: Yale University
Summary
This study addresses real-world use of long-acting injectable cabotegravir/rilpivirine (CAB/RPV LA) by evaluating implementation and clinical outcomes of a pharmacist-led collaborative drug therapy management model (CDTM+) that will be expanded for telehealth outreach to women with health-related social needs (HRSN).
Official title: Project Tara: Pharmacist-led Intervention for Injectable HIV Treatment for Women With Health-related Social Needs
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2024-08-01
Completion Date
2027-03
Last Updated
2026-02-03
Healthy Volunteers
Yes
Conditions
Interventions
Collaborative drug therapy management model
CDTM+ is an interdisciplinary approach to patient care in which clinicians collaborate with pharmacists to provide and manage patient drug therapy.
Cabotegravir/Rilpivirine
Long-acting injectable treatment prescribed to treat HIV-1 infection in people 12 years and older and who weigh at least 77 lbs (35kg), to replace their current HIV-1 medicines when their healthcare provider determines they meet certain requirements.
Locations (1)
Yale Clinical and Community Research
New Haven, Connecticut, United States